Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia

Anna Saorin(University Children's Hospital Zurich), Beat Bornhäuser(University Children's Hospital Zurich), Fabio D. Steffen(University Children's Hospital Zurich), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Aneta Drakul(University Children's Hospital Zurich), Samanta Kisele(University Children's Hospital Zurich), Jin Wang(Baylor College of Medicine), Dong Lu(Baylor College of Medicine), James Kim(University Children's Hospital Zurich), Xin Yu(Baylor College of Medicine), Anna Dehler(University Children's Hospital Zurich), Bartimée Galvan(University Children's Hospital Zurich)
Blood
May 13, 2025
10.1182/blood.2025028938
Cited by 11

Related Papers

Chromosomal transposition of <i>PiggyBac</i> in mouse embryonic stem cells
|Proceedings of the National Academy of Sciences|2008|397
Reprogramming of T Cells to Natural Killer–Like Cells upon <i>Bcl11b</i> Deletion
|Science|2010|358
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
|Blood|2009|347
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
|Journal of Clinical Investigation|2010|311
<i>IKZF1</i><sup>plus</sup>Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2018|304